Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07530380 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

UCAR T-cell Therapy Targeting CD19/BCMA in Relapsed/Refractory Autoimmune Hemolytic Anemia

StatusRecruiting
PhaseEarly Phase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This is an investigator-initiated trial to evaluate the safety and efficacy of universal allogeneic anti-CD19/BCMA CAR T-cells in AIHA who have failed ≥ 3 lines of therapy
Trial Details
NCT Number NCT07530380
Lead Sponsor The Second Hospital of Anhui Medical University
Conditions
(from sponsor)		 AIHA - Warm Autoimmune Hemolytic Anemia, UCART
Enrollment 15 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov